M&A Deal Summary |
|
---|---|
Date | 2024-11-22 |
Target | Northwest Pump |
Sector | Energy Services and Equipment |
Buyer(s) | H.I.G. Private Equity |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1993 |
PE ASSETS | 65.0B USD |
Size | Mega |
Type | Sector Agnostic |
HIG Private Equity is the private equity arm of HIG Capital LLC. The firm focuses on management buyouts, growth equity investments, and recapitalizations of middle market companies with an enterprise value of $50 - $1000 million. The Firm also will consider add-on acquisitions, industry consolidations, going-privates, and corporate divestitures. Sectors of interest include aerospace, building materials, business services, consumer products, distribution, healthcare, infrastructure, contracting, manufacturing, media, oil & gas services, IT, and transportation. HIG was formed in 1993 and has offices in Miami, Atlanta, Boston, and San Francisco. HIG's European affiliate is HIG Europe with offices in London, Hamburg, and Paris.
DEAL STATS | # |
---|---|
Overall | 370 of 370 |
Sector (Energy Services and Equipment) | 7 of 7 |
Type (Buyout (LBO, MBO, MBI)) | 113 of 113 |
State (Oregon) | 1 of 1 |
Country (United States) | 246 of 246 |
Year (2024) | 23 of 23 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2024-11-21 |
Deenova
Gragnano Trebbiense, Italy Deenova is a provider of advanced services to hospitals. It offers integrated turn-key solutions to hospitals for the traceability and management of unit dose drugs and medical devices. Deenova solutions, which include proprietary software, patented robotic technologies and specialist support services, enable drugs and medical devices management from digital prescription to automated personalized unit dose treatment, up to software controlled administration to patients. Complete traceability of medications and medical devices allows significant reduction in errors in therapy management and in related waste, resulting in material savings for hospitals in terms of reduced drug spending and clinical risk. Deenova was founded in 2004 and is based in Gragnano Trebbiense, Italy. |
Sell | - |